Revenue: The sum of all revenue fields included for a company's operating activities.
Anebulo Pharmaceuticals, Inc. (ANEB) Revenue data is not available.
| Income Statement Financials | |
|
Revenue |
-- |
$-8.20M |
|
-- |
|
-- |
|
$8.31M |
|
$-8.31M |
|
$0.11M |
|
$-8.20M |
|
$-8.20M |
|
$-8.20M |
|
$-8.20M |
|
$-8.20M |
|
$-8.20M |
|
$-8.31M |
|
$-8.16M |
|
25.82M |
|
25.82M |
|
$-0.32 |
|
$-0.32 |
|
| Balance Sheet Financials | |
$3.51M |
|
-- |
|
$0.57M |
|
$4.07M |
|
$0.26M |
|
-- |
|
-- |
|
$0.26M |
|
$3.81M |
|
$3.81M |
|
$3.81M |
|
25.93M |
|
| Cash Flow Statement Financials | |
$-8.09M |
|
-- |
|
$-0.06M |
|
$11.25M |
|
$3.09M |
|
$-8.15M |
|
$0.76M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.46 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.09M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-215.13% |
|
-215.12% |
|
-201.36% |
|
-215.12% |
|
$0.15 |
|
$-0.31 |
|
$-0.31 |
|